Additionally, gene therapy strategies that target the LPL gene or its regulatory pathways could provide personalized treatments, particularly for individuals with T2D who harbor LPL gene polymorphisms that reduce its activity [8]. Here, LPL is linked to type 2 diabetes mellitus.